StockNews.com downgraded shares of Kewaunee Scientific (NASDAQ:KEQU – Free Report) from a buy rating to a hold rating in a research report sent to investors on Friday morning.
Kewaunee Scientific Stock Performance
NASDAQ KEQU opened at $47.58 on Friday. Kewaunee Scientific has a 1 year low of $30.74 and a 1 year high of $71.33. The company has a debt-to-equity ratio of 0.45, a current ratio of 2.64 and a quick ratio of 2.13. The firm has a market cap of $136.65 million, a price-to-earnings ratio of 7.54 and a beta of 0.71. The company has a fifty day moving average price of $58.59 and a 200-day moving average price of $47.92.
Kewaunee Scientific (NASDAQ:KEQU – Get Free Report) last posted its earnings results on Wednesday, March 12th. The technology company reported $1.09 earnings per share (EPS) for the quarter. Kewaunee Scientific had a net margin of 9.39% and a return on equity of 25.83%. The firm had revenue of $67.17 million during the quarter.
Insider Activity at Kewaunee Scientific
Hedge Funds Weigh In On Kewaunee Scientific
Several institutional investors have recently added to or reduced their stakes in the stock. Bank of America Corp DE lifted its holdings in Kewaunee Scientific by 2,605.9% during the fourth quarter. Bank of America Corp DE now owns 460 shares of the technology company’s stock valued at $28,000 after purchasing an additional 443 shares during the last quarter. IFP Advisors Inc purchased a new stake in Kewaunee Scientific during the fourth quarter valued at about $36,000. O Shaughnessy Asset Management LLC lifted its holdings in Kewaunee Scientific by 3.3% during the fourth quarter. O Shaughnessy Asset Management LLC now owns 28,008 shares of the technology company’s stock valued at $1,733,000 after purchasing an additional 891 shares during the last quarter. JPMorgan Chase & Co. lifted its holdings in Kewaunee Scientific by 18,000.0% during the third quarter. JPMorgan Chase & Co. now owns 905 shares of the technology company’s stock valued at $30,000 after purchasing an additional 900 shares during the last quarter. Finally, Ritholtz Wealth Management lifted its holdings in Kewaunee Scientific by 15.6% during the fourth quarter. Ritholtz Wealth Management now owns 12,619 shares of the technology company’s stock valued at $781,000 after purchasing an additional 1,706 shares during the last quarter. Institutional investors own 32.69% of the company’s stock.
Kewaunee Scientific Company Profile
Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.
Featured Articles
- Five stocks we like better than Kewaunee Scientific
- What is diluted earnings per share (Diluted EPS)?
- Rubrik Stock’s V-Bottom Reversal Signals a Major Rally Ahead
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- How Super Micro Computer Stock Is Defying the Market Sell-Off
- Conference Calls and Individual Investors
- AppLovin vs. HPE: Which Tech Stock Can Bounce Back Faster?
Receive News & Ratings for Kewaunee Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kewaunee Scientific and related companies with MarketBeat.com's FREE daily email newsletter.